Ozempic-style drugs treat type 1 diabetes, not only type 2, study finds. Jennifer Zieba. Wed, July 2, 2025 at 9:00 PM UTC. When you buy through links on our articles, Future and its syndication ...

Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

When you hear the name Ozempic, you likely think of diabetes treatment. That makes sense, as semaglutide was first approved in 2017 to help people with type 2 diabetes regulate […] ...

GLP-1 agonists, including liraglutide, are typically used to control blood sugar levels in type 2 diabetes and to promote weight loss. These drugs mimic a hormone released after eating, helping to ...

The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School of Medicine suggests.

For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes ...

Originally designed to manage type 2 diabetes, the GLP-1 drug Ozempic has become a global phenomenon for its off-label weight loss effects. But as its popularity soars, so do reports of a lesser ...

Ozempic-style drugs treat type 1 diabetes, not only type 2, study finds. News. By Jennifer Zieba published 2 July 2025 A clinical trial for semaglutide, the active ingredient in Ozempic, found ...